When I interviewed Jay Bhattacharya in October 2024, he was a Stanford professor, physician, economist, and one of the country’s most prominent critics of COVID policy. He had coauthored the Great Barrington Declaration, challenging the lockdown consensus and advocating focused protection of the vulnerable. His willingness to question Anthony Fauci and the public-health establishment had earned him considerable hostility.
Today, the circumstances are rather different. Bhattacharya became director of the National Institutes of Health in April 2025 and subsequently served as acting CDC director. The academic who challenged the establishment found himself running a substantial part of it. Revisiting our conversation offers an unusual opportunity to hear his arguments before he assumed governmental authority.
The original video interview, also published on my website, concerned the scientific, political, and institutional failures of the pandemic. Much of what we discussed remains pertinent, particularly the question of how medical science became subordinate to bureaucratic authority.
When public health forgot economics
Bhattacharya holds both medical and economics degrees from Stanford. That combination proved particularly useful during COVID, when public-health officials seemed almost willfully indifferent to the costs of their interventions.
Every medical decision involves tradeoffs. Every economic decision involves opportunity costs. Yet pandemic policy frequently proceeded as though reducing viral transmission were the only outcome worth measuring. School closures, deferred medical care, unemployment, and the isolation of older people became secondary concerns.
Jay’s argument was straightforward: Public health must consider the total consequences of its decisions. The benefits of an intervention cannot be evaluated independently of the injuries it causes.
The Great Barrington Declaration applied that reasoning precisely. It advocated focused protection of people at greatest risk while allowing others to resume ordinary activities. Its opponents portrayed this as a proposal to abandon the vulnerable and permit uncontrolled infection, a characterization that distorted the authors’ position.
The larger problem was the substitution of authority for argument. Fauci’s suggestion that criticism of him amounted to criticism of science was particularly revealing. Science depends upon disagreement, competing hypotheses, and the correction of error. No scientist, however accomplished, can reasonably claim to embody the enterprise.
Fauci’s transformation
I had explored Fauci’s institutional career in my Brownstone essay, Fauci’s DNA of Caring. During the AIDS epidemic, Fauci had learned to work with patients and activists whose objections sometimes challenged the medical establishment. By COVID, he appeared considerably less receptive to dissent.
I described this as the difference between Fauci 1.0 and Fauci 2.0. Bhattacharya’s explanation focused on the incentives of bureaucratic leadership. Fauci had spent decades mastering the NIH system, directing research priorities, allocating resources, and cultivating institutional influence. Such skills do not necessarily produce sound clinical judgments.
Indeed, institutional success may reward behavior that conflicts with scientific skepticism. An administrator who regards the preservation of his agency’s authority as essential may become increasingly resistant to evidence that questions its decisions.
The organized hostility toward the Great Barrington Declaration illustrated the problem. Rather than engaging its epidemiological arguments, senior officials sought to discredit its authors. Scientific disagreement had become a threat to institutional legitimacy.
Fauci’s gambit
Perhaps the most provocative portion of our conversation concerned the relationship between Fauci’s longstanding interest in vaccine technology and the decisions made during COVID.
Bhattacharya proposed that the expectation of an effective vaccine may have encouraged officials to pursue prolonged restrictions despite their social and economic costs. If a vaccine was understood to be the ultimate solution, delaying infections until its arrival could seem sensible, even when the delays themselves imposed enormous harms.
I pressed the argument further. Fauci had long championed vaccine development, including novel technological platforms, and his agency occupied a central position in financing biomedical research. Could his professional investment in these approaches have influenced his judgment about the pandemic?
We also considered whether institutional self-protection might have influenced the government’s handling of questions about the virus’s origins. These were hypotheses about incentives and motivations, not proof of Fauci’s private intentions or responsibility for the pandemic. Nonetheless, examining institutional incentives is legitimate, particularly when official explanations fail to account adequately for seemingly contradictory decisions.
The danger is familiar to any physician. A treatment becomes so central to the practitioner’s thinking that the patient gradually becomes secondary. In public health, the consequences of such a reversal can extend across an entire population.
The vulnerable and the forgotten
Our discussion turned to nursing homes, where some of the pandemic’s gravest failures occurred. Governments imposed sweeping restrictions upon comparatively healthy populations while failing, particularly early in the pandemic, to protect many frail older people.
I raised the question of baseline mortality among nursing-home residents. These populations often have substantial comorbidities and limited remaining life expectancy. Their underlying mortality rates are indispensable to any serious assessment of excess deaths and the effects of an epidemic.
The point is neither to minimize individual deaths nor to dismiss the consequences of infection. It is to distinguish the mortality attributable to a new pathogen from mortality that would otherwise have occurred, and to examine whether the interventions themselves caused additional injury.
The enormous differences in COVID mortality risk by age and health status should have informed policy from the beginning. Instead, authorities repeatedly adopted restrictions that ignored these differences, often imposing substantial burdens on children and younger adults while failing to concentrate sufficient attention on those at greatest risk.
Censorship as public-health policy
The final portion of our conversation addressed Bhattacharya’s involvement in the litigation originally called Missouri v. Biden, subsequently decided by the Supreme Court as Murthy v. Missouri.
The plaintiffs challenged federal officials’ communications with social-media companies concerning the suppression of controversial viewpoints. The underlying constitutional issue was whether government officials could use private platforms to accomplish restrictions on speech that the government itself could not lawfully impose.
Bhattacharya explained the difficulty of proving such interference. Government pressure can operate through informal communications, implied threats, and continuing relationships with companies whose business interests depend partly upon regulatory goodwill.
In June 2024, the Supreme Court dismissed the case for lack of standing, concluding that the plaintiffs had not adequately established the causal connection necessary to obtain prospective relief. The Court did not decide that the challenged governmental conduct was constitutional. It declined to reach that question.
This distinction deserves emphasis. A legal defeat based upon standing does not vindicate the underlying conduct, and the constitutional questions remain significant. Scientific debate becomes especially vulnerable when government agencies acquire indirect influence over which hypotheses and criticisms the public may hear.
From critic to administrator
Near the conclusion, I asked Bhattacharya how American public health might recover from the failures of the pandemic. He defended the legitimate purposes of public health while insisting upon intellectual humility, scientific openness, and respect for individual liberty.
At the time, neither of us knew that he would soon become responsible for directing the NIH. His appointment transformed what had been an academic critique into a practical test of institutional reform.
The transition is intellectually fascinating. It is relatively easy to identify the errors of an establishment from the outside. Correcting them from within requires confronting entrenched incentives, professional loyalties, and the administrative machinery that helped produce those errors.
That is what makes this October 2024 conversation worth revisiting. Bhattacharya’s arguments remain available for comparison with his subsequent decisions. The scientist who demanded accountability from others must now accept the same scrutiny himself.
The most persuasive defense of scientific freedom is a consistent one, especially when the former dissenter finds himself in charge.
*An October 2024 conversation with the future NIH director about lockdowns, mRNA vaccines, government censorship, and the institutional incentives behind America’s pandemic response.
Discover more from Randy Bock MD PC
Subscribe to get the latest posts sent to your email.
